MIAMI BEACH, Fla., April 27, 2018 -- via OTC PR WIRE -- SNM Global Holdings (OTC:SNMN) is excited to announce the assembly of a group of medical cannabis industry experts from the financial, medical, and legal sectors.
During the recent legislative session in the Maryland legislature, a bill was passed to authorize the Maryland Medical Cannabis Commission to reopen the application process and grant several additional Medical Cannabis Grower and Processor licenses throughout the state. We will be working diligently over the next several months to complete the application process, identify key areas within the state of Maryland for suitable facilities, and engage horticulture experts, as well as seasoned medical operations personnel to position SNM to be awarded either one or both of these new license opportunities.
"SNM is excited to have become involved with industry experts in each stage of the medical cannabis arena, from grow operations all the way down to retail sales at the dispensary level," stated SNM CEO Troy Lowman, "the legal counsel we have retained to assist us with our Grower and Processing applications to the Maryland Medical Cannabis Commission has a proven track record of assisting their clients in acquiring various medical cannabis licenses." “It is very humbling to realize we will be a part of a rapidly developing industry that will help so many people achieve quality of life living while with cancer and so many other diseases,” says Lowman.
The process from application to becoming fully operational is expected to take approximately 365 days.
Contact Information
Troy Lowman, CEO
Phone (410)733-6551
Email: [email protected]
Safe Harbor for Forward-Looking Statements. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospect s and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commissions. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments
Luxshare Shares Rise as First-Half Profit Jumps 18%
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
California Seeks Paramount Divestitures in Warner Bros. Merger
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Tesla Raises Cybertruck Prices by $5,000 in US
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
SK Hynix Shares Fall as Workers Reject Wage Deal
Trump Buys SpaceX Shares After Record IPO
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover
Ampol Profit Surges as Refining Margins Hit Record Highs 



